dailypolitical.com
Positivewww.dailypolitical.com ·
insider selling sionna therapeutics nasdaqsion director sells 59767 shares of stock
RETIREMENTWB_2690_CATEGORIES_OF_EMPLOYMENTWB_2670_JOBSWB_2689_JOBS_DIAGNOSTICS
Topic context
This topic has been covered 217738 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedNo concrete commercial mechanism. Insider sale is pre-planned and small relative to holdings; no supply, demand, or regulatory impact on any sector. Weak signal, no material sector impact detected.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Sionna Therapeutics director Peter Thompson sold 59,767 shares at $44.58 on May 8, 2026.
- Sale was pre-arranged under Rule 10b5-1 trading plan.
- Stock rose 3.9% to $45.95 on May 11, 2026.
- 52-week range: $11.77 to $48.45.
- EPS for quarter ending March 2, 2026: ($0.46), beating estimates.